Candida infections in non-neutropenic children after the neonatal period

Expert Review of Anti-Infective Therapy

Volumn 9, Issue 10, 2011, Pages 923-940

  Hacimustafaoglu, Mustafa ^a   Celebi, Solmaz ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

antifungal therapy; Candida; children; diagnosis; infection; non neutropenic

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; ANTIFUNGAL AGENT; BUTACONAZOLE; CASPOFUNGIN; CLOTRIMAZOLE; ECHINOCANDIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; MICAFUNGIN; MICONAZOLE; NYSTATIN; PYRROLE; TERCONAZOLE; TIOCONAZOLE; TRIAZOLE; UNCLASSIFIED DRUG; VORICONAZOLE;

ANTIBODY DETECTION; ANTIGEN DETECTION; ASYMPTOMATIC INFECTION; CANDIDA ALBICANS; CANDIDEMIA; CANDIDIASIS; CANDIDURIA; CARDIAC CANDIDIASIS; CENTRAL NERVOUS SYSTEM CANDIDIASIS; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; DRUG BIOAVAILABILITY; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; ESOPHAGUS CANDIDIASIS; FUNGAL COLONIZATION; FUNGAL DETECTION; FUNGAL VIRULENCE; FUNGUS GROWTH; FUNGUS TRANSMISSION; GASTROINTESTINAL CANDIDIASIS; GRAM STAINING; HIGH RISK INFANT; HISTOPATHOLOGY; HUMAN; INFECTION RISK; LABORATORY TEST; LOADING DRUG DOSE; MOLECULAR PATHOLOGY; MORTALITY; MUCOCUTANEOUS CANDIDIASIS; MUSCULOSKELETAL CANDIDIASIS; MYCOSIS; NEUTROPENIA; NEWBORN; NEWBORN PERIOD; NONHUMAN; OCULAR CANDIDIASIS; OROPHARYNX CANDIDIASIS; PERITONEAL CANDIDIASIS; POLYMERASE CHAIN REACTION; PREVALENCE; PYELONEPHRITIS; RADIODIAGNOSIS; RESPIRATORY TRACT CANDIDIASIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SKIN CANDIDIASIS; URINARY TRACT CANDIDIASIS; VAGINA CANDIDIASIS;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA; CANDIDEMIA; CATHETER-RELATED INFECTIONS; CHILD; CROSS INFECTION; DEOXYCHOLIC ACID; DRUG COMBINATIONS; ECHINOCANDINS; FLUCONAZOLE; FLUCYTOSINE; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS; LEUKOCYTE COUNT; MYCOLOGICAL TYPING TECHNIQUES; NEUTROPHILS; SURVIVAL RATE; UNITED STATES;

EID: 80053630376     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.11.104     Document Type: Review

References (115)

1. Fridkin SK. The changing face of fungal infections in health care settings. Clin. Infect. Dis. 41, 1455-1460 (2005 (Pubitemid 41579989)
2. Celebi S, Hacimustafaoglu M, Ozdemir O, Ozkaya G. Nosocomial candidemia in children: Results of a 9-year study. Mycoses 51, 248-257 (2008). . Reviews the epidemiology of hospital-acquired candidemia and risk factors for mortality in children with candidemia. (Pubitemid 351502573)
3. Edwards JE. Candida species. In:Principles and Practice of Infectious Disease (7th Edition). Mandell GL, Douglas RG, Bennett JE (Eds). Churchill Livingstone, NY, USA, 2289-2306 (2010
4. Knapp KM, Flynn PM. Candidiasis. In:Textbook of Pediatric Infectious Disease (6th Edition). Feigin RD, Cherry JD, Demler-Harrison GJ, Kaplan SL (Eds). Saunders, PA, USA, 2741-2751 (2009
5. Silva AP, Miranda IM, Lisboa C, Pina-Vaz C, Rodrigues AG. Prevalence, distribution, and antifungal susceptibility profiles of Candida parapsilosis, C. orthopsilosis, and C. metapsilosis in a tertiary care hospital. J. Clin. Microbiol. 47, 2392-2397 (2009
6. Trofa D, Gacser A, Nosanchuk JD. Candida parapsilosis, an emerging fungal pathogen. Clin. Microbiol. Rev. 21, 606-625 (2008
7. Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect. Dis. 3, 685-702 (2003 (Pubitemid 37345347)
8. Conde-Rosa A, Amador R, Pérez-Torres D et al. Candidemia distribution, associated risk factors, and attributed mortality at a university-based medical center. PR Health Sci. J. 29, 26-29 (2010
9. Filioti J, Spiroglou K, Panteliadis CP, Roilides E. Invasive candidiasis in pediatric intensive care patients: Epidemiology, risk factors, management, and outcome. Intensive Care Med. 33, 1272-1283, (2007 (Pubitemid 47036901)
10. Blyth CC, Chen SC, Slavin MA et al. Not just little adults: Candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients. Pediatrics 123, 1360-1368 (2009
11. Zaoutis TE, Argon J, Chu J et al. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: A propensity analysis. Clin. Infect. Dis. 41, 1232-1239 (2005 (Pubitemid 41532664)
12. El-Nawawy AA, Abd El-Fattah MM, Metwally HA, Barakar SS, Hasan IA. One year study of bacterial and fungal nosocomial infections among patients in pediatric intensive care unit (PICU) in Alexandria. J. Trop. Pediatr. 52, 185-191 (2006 (Pubitemid 43997455)
13. Cuenca-Estrella M, Rodriguez D, Almirante B et al. In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: Results from a population based active surveillance programme, Barcelona, Spain, 2002-2003. J. Antimicrob. Chemother. 55, 194-199 (2005 (Pubitemid 40331145)
14. Abelson JA, Moore T, Bruckner D, Deville J, Nielsen K. Frequency of fungemia in hospitalized pediatric inpatients over 11 years at a tertiary care institution. Pediatrics 116, 61-67 (2005
15. Neu N, Malik M, Lunding A et al. Epidemiology of candidemia at a children's hospital, 2002 to 2006. Pediatr. Infect. Dis. J. 28, 806-809 (2009
16. San Miguel LG, Cobo J, Otheo E, Sanchez-Sousa A, Abraira V, Moreno S. Secular trends of candidemia in a large tertiary-care hospital from 1988 to 2000: Emergence of Candida parapsilosis. Infect. Control. Hosp. Epidemiol. 26, 548-552 (2005 (Pubitemid 40896145)
17. Zaoutis TE, Coffin SE, Chu JH et al. Risk factors for mortality in children with candidemia. Pediatr. Infect. Dis. J. 24, 736-739 (2005 (Pubitemid 41140963)
18. Zaoutis TE, Prasad PA, Localio AR et al. Risk factors and predictors for candidemia in pediatric intensive care unit patients: Implications for prevention. Clin. Infect. Dis. 51, 38-45 (2010). Highlights the analysis of predisposing factors associated with candidemia and prevention of candidemia in pediatric intensive care unit patients.
19. San Miguel LG, Cobo J, Otheo E et al. Candidemia in pediatric patients with congenital heart disease. Diagn. Microbiol. Infect. Dis. 55, 203-207 (2006 (Pubitemid 43928407)
20. Zaoutis T. Candidemia in children. Curr. Med. Res. Opin. 26, 1761-1768 (2010). Highlights the analysis of predisposing factors associated with candidemia and prevention of candidemia in pediatric intensive care unit patients.
21. San Miguel LG, Cobo J, Otheo E et al. Candidemia in pediatric patients with congenital heart disease. Diagn. Microbiol. Infect. Dis. 55, 203-207 (2006 (Pubitemid 43928407)
22. Zaoutis T. Candidemia in children. Curr. Med. Res. Opin. 26, 1761-1768 (2010). Recent update on invasive candidiasis in pediatric patients including risk factors, incidence, species distribution and antifungal therapy.
23. Marodi L, Johnston RB Jr. Invasive Candida species disease in infants and children: Occurrence, risk factors, management, and innate host defense mechanisms. Curr. Opin. Pediatr. 19, 693-697 (2007 (Pubitemid 350145239)
24. Charles PE, Dalle F, Aube H et al. Candida spp. colonization significance in critically ill medical patients: A prospective study. Intensive Care Med. 31, 393-400 (2005
25. Singhi S, Rao DS, Chakrabarti A. Candida colonization and candidemia in a pediatric intensive care unit. Pediatr. Crit. Care Med. 9, 91-95 (2008
26. Zaoutis T, Prasad P, Localio RA et al. Risk factors for candidemia in the pediatric intensive care unit. Abstracts of the Society for Healthcare Epidemiology of America Annual Meeting, San Diego, CA, USA, 19-22 March 2009 (Abstract 503
27. Almuneef MA, Memish ZA, Balkhy HH, Hijazi O, Cunningham G, Francis C. Rate, risk factors and outcomes of catheter-related bloodstream infection in a paediatric intensive care unit in Saudi Arabia. J. Hosp. Infect. 62, 207-213 (2006 (Pubitemid 43056663)
28. Phaller MA, Diekman DJ. Epidemiology of invasive candidiasis: A persistent public health problem. Clin. Microbiol. Rev. 20, 133-163 (2007
29. Stamos JK, Rowley AH. Candidemia in a pediatric population. Clin. Infect. Dis. 20, 571-575 (1995
30. Pappas PG, Rex JH, Lee J et al. A prospective observational study of candidemia: Epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin. Infect. Dis. 37, 634-643 (2003 (Pubitemid 37100802)
31. Zaoutis TE, Greves HM, Lautenbach E, Bilker WB, Coffin SE. Risk factors for disseminated candidiasis in children with candidemia. Pediatr. Infect. Dis. J. 23, 635-664 (2004). Reviews the identification of independent risk factors for disseminated candidiasis in pediatric patients with candidemia.
32. Weinberger M, Leibovici L, Perez S et al. Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality. J. Hosp. Infect. 61, 146-154 (2005 (Pubitemid 41283339)
33. Paganini H, Brieshcke TR, Santos P, Seu S, Rosanova MT. Risk factors for nosocomial candidemia: A case-control study in children. J. Hosp. Infect. 50, 304-308 (2002 (Pubitemid 38001813)
34. Naglik JR, Rodgers CA, Shirlaw PJ et al. Differential expression of Candida albicans secreted aspartyl proteinase and phospholipase B genes in humans correlates with active oral and vaginal infections. J. Infect. Dis.188, 469-479 (2003 (Pubitemid 36960660)
35. Villar CC, Kashleva H, Nobile CJ, Mitchell AP, Dongari-Bagtzoglou A. Mucosal tissue invasion by Candida albicans is associated with E-cadherin degradation, mediated by transcription factor Rim101p and protease Sap5p. Infect. Immun. 75, 2126-2135 (2007 (Pubitemid 46744298)
36. Samonis G, Gikas A, Toloudis P et al. Prospective study of the impact of broad-spectrum antibiotics on the yeast flora of the human gut. Eur. J. Clin. Microbiol. Infect. Dis. 13, 665-667 (1994 (Pubitemid 24286870)
37. Bendel CM, Wiesner SM, Garni RM et al. Cecal colonization and systemic spread of Candida albicans in mice treated with antibiotics and dexamethasone. Pediatr. Res. 51, 290-295 (2002 (Pubitemid 34174963)
38. Chapman RL, Faix RG. Invasive neonatal candidiasis: An overview. Semin. Perinatol. 27, 352-356 (2003 (Pubitemid 37363187)
39. Bernhardt H. Candida in the ecological system of the orointestinal tract. Mycoses 39(Suppl. 1), 44-47 (1996 (Pubitemid 26257396)
40. Knoke M. Gastrointestinal microecology of humans and Candida. Mycoses 42(Suppl. 1), 30-34 (1999
41. Bernhardt H, Knoke M. Mycological aspects of gastrointestinal microflora. Scand. J. Gastroenterol. (Suppl. 222), 102-106 (1997 (Pubitemid 27196273)
42. Naglik J, Albrecht A, Bader O, Hube B. Candida albicans proteinases and host/pathogen interactions. Cell Microbiol. 6, 915-926 (2004 (Pubitemid 39255605)
43. Falgier C, Kegley S, Podgorski H et al. Candida species differ in their interactions with immature human gastrointestinal epithelial cells. Pediatr. Res. 69, 384-389 (2011
44. Deng Z, Kiyuna A, Hasegawa M, Nakasone I, Hosokawa A, Suzuki M. Oral candidiasis in patients receiving radiation therapy for head and neck cancer. Otolaryngol. Head Neck Surg. 143, 242-247 (2010
45. Buhl R. Local oropharyngeal side effects of inhaled corticosteroids in patients with asthma. Allergy 61, 518-526 (2006
46. Pienaar ED, Young T, Holmes H. Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children. Cochrane Database Syst. Rev. 19, CD003940 (2006
47. Ahonen P, Myllarniemi S, Sipila I, Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N. Engl. J. Med. 322, 1829-1836 (1990 (Pubitemid 20200407)
48. Kirkpatrick CH. Chronic mucocutaneous candidiasis. Pediatr. Infect. Dis. J. 20, 197-206 (2001 (Pubitemid 32151946)
49. Mimidis K, Papadopoulos V, Margaritis V et al. Predisposing factors and clinical symptoms in HIV-negative patients with Candida oesophagitis: Are they always present? Int. J. Clin. Pract. 59, 210-213 (2005 (Pubitemid 40331223)
50. Aun MV, Ribeiro MR, Costa Garcia CL, Agondi RC, Kalil J, Giavina-Bianchi P. Esophageal candidiasis-an adverse effect of inhaled corticosteroids therapy. J. Asthma 46, 399-401 (2009
51. Aun MV, Ribeiro MR, Garcia CLC, Agondi RC, KalilmJ, Giavina-Bianchi P. Esophageal candidiasis-an adverse effect of inhaled corticosteroids therapy. J. Asthma 46, 399-401 (2009
52. Salman AG, Mansour DE, Radwan AA, Mansour LE. Polymerase chain reaction in pediatric post-traumatic fungal endophthalmitis among Egyptian children. Ocul. Immunol. Inflamm. 18, 127-132 (2010
53. Pappas PG, Kauffman CA, Andes D et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 48, 503-535 (2009). Important 'Expert Panel Clinical Guideline' for the therapy of Candida infections.
54. Perez Blazquez E. Ophtalmoscopic examination in critically ill non-neutropenic patients: Candida endophtalmitis. Rev. Iberoam. Micol. 23, 16-19 (2006 (Pubitemid 43241069)
55. Pasqualotto AC. Candida and the paediatric lung. Paediatr. Resp. Rev. 10, 186-191 (2009
56. Meersseman W, Lagrou K, Spriet I et al. Significance of the isolation of Candida species from airway samples in critically ill patients: A prospective, autopsy study. Intensive Care Med. 35, 1526-1531 (2009
57. Wood GC, Mueller EW, Croce MA et al. Candida spp. isolated from bronchoalveolar lavage: Clinical significance in critically ill trauma patients. Intensive Care Med. 32, 599-603 (2006
58. Montravers P, Dupont H, Cauzit R et al. Candida as a risk factor for mortality in peritonitis. Crit. Care Med. 34, 646-652 (2006
59. Unal A, Kocyigit I, Sipahioglu MH, Tokgoz B, Oymak O, Utas C. Fungal peritonitis in peritoneal dialysis: An analysis of 21 cases. Int. Urol. Nephrol. 43, 211-213 (2011). 58 Matuszkiewicz-Rowinska J. Update on fungal peritonitis and its treatment. Perit. Dial. Int. 29, 161-165 (2009
60. Warady BA, Bashir M, Donaldson LA. Fungal peritonitis in children receiving peritoneal dialysis: A report of the NAPRTCS. Kidney Int. 58, 384-389 (2000 (Pubitemid 30429885)
61. Raaijmakers R, Schröder C, Monnens L, Cornelissen E, Warris A. Fungal peritonitis in children on peritoneal dialysis. Pediatr. Nephrol. 22, 288-293 (2007 (Pubitemid 44964331)
62. Kauffman CA. Candiduria. Clin. Infect. Dis. 41, S371-S376 (2005 (Pubitemid 41266735)
63. Chen SC, Tong ZS, Lee OC et al. Clinician response to Candida organisms in the urine of patients attending hospital. Eur. J. Clin. Microbiol. Infect. Dis. 27, 201-208 (2008
64. Carvalho M, Guimaraes CM, Mayer JR Jr., Bordignon GP, Queiroz-Telles F. Hospital associated funguria: Analysis of risk factors, clinical presentation and outcome. Braz. J. Infect. Dis. 5, 313-318. (2001
65. Binelli CA, Moretti ML, Assis RS et al. Investigation of the possible association between nosocomial candiduria and candidemia. Clin. Microbiol. Infect. 12, 538-543 (2006
66. Kale H, Narlawar RS, Rathod K. Renal fungal ball: An unusual sonographic finding. J. Clin. Ultrasound 30, 178-180 (2002 (Pubitemid 34184975)
67. Millar BC, Jugo J, Moore JE. Fungal endocarditis in neonates and children. Pediatr. Cardiol. 26, 517-536 (2005 (Pubitemid 43015782)
68. Falcone M, Barzaghi N, Carosi G et al. Candida infective endocarditis: Report of 15 cases from a prospective multicenter study. Medicine (Baltimore) 88, 160-168 (2009
69. Rabinovici R, Szewczyk D, Ovadia P et al. Candida pericarditis: Clinical profile and treatment. Ann. Thorac. Surg. 63, 1200-1204 (1997 (Pubitemid 27191705)
70. Neughebauer B, AlvarezV, Harb T, Keefer M. Constrictive pericarditis caused by Candida glabrata in an immunocompetent patient: Case report and review of literature. Scand. J. Infect. Dis. 34, 615-619 (2002 (Pubitemid 35012347)
71. Dato VM, Dajani AS. Candidemia in children with central venous catheters: Role of catheter removal and amphotericin B therapy. Pediatr. Infect. Dis. J. 9, 309-314 (1990 (Pubitemid 20157125)
72. Hacimustafaoglu M, Ener B, Tarim O, Kilic S, Tanritanir A, Ildirim I. Systemic candidiasis with acute Epstein-Barr virus infection. Acta Paediatr. 86, 1267-1270 (1997 (Pubitemid 27509446)
73. Hacimustafaoglu M, Cil E, Sarisözen B, Zincirci M, Ildirim I. Bilateral septic arthritis of the knee joint in three children caused by unusual infectious agents. Pediatr. Int. 43, 697-700 (2001 (Pubitemid 33071140)
74. Swanson J, Hughes PA, Messer SA et al. Candida albicans arthritis one year after successful treatment of fungemia in a healthy infant. J. Pediatr. 129, 688-694 (1996 (Pubitemid 27498278)
75. Miller DJ, Mejicano GC. Vertebral osteomyelitis: Due to Candida species: Case report and literature review. Clin. Infect. Dis. 33, 523-530 (2001 (Pubitemid 32709586)
76. Sanchez-Portocarrero J, Perez-Cecilia E, Corral O, Romero-Vivas J, Picazo JJ. The central nervous system and infection by Candida species. Diagn. Microbiol. Infect. Dis. 37, 169-179 (2000 (Pubitemid 30440728)
77. Verweij PE, van der Lee HAL, Rijs AJM. The role of conventional diagnostic tools. In:Diagnosis of Fungal Infections Maertens JA, Marr KA (Eds). Informa Healthcare, NY, USA, 19-39 (2007
78. Meyer MH, Letscher-Bru V, Jaulhac B, Waller J, Candolfi E. Comparison of Mycosis IC/F and plus Aerobic/F media for diagnosis of fungemia by the Bactec 9240 system. J. Clin. Microbiol. 42, 773-777 (2004 (Pubitemid 38222661)
79. Verduyn Lunel FM, Meis JF, Voss A. Nosocomial fungal infections: Candidemia. Diagn. Microbiol. Infect. Dis. 34, 213-220 (1999 (Pubitemid 29287215)
80. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann. Surg. 220, 751-758 (1994 (Pubitemid 24376373)
81. Ostrosky-Zeichner L. Invasive yeast infections. In:Diagnosis of Fungal Infections Maertens JA, Marr KA (Eds). Informa Healthcare, NY, USA, 221-238 (2007
82. Morrison CJ, Warnock DW. Serodiagnosis: Antibody and antigen detection. In:Diagnosis of Fungal Infections Maertens JA, Marr KA (Eds). Informa Healthcare, NY, USA, 65-119 (2007
83. Yeo SF, Wong B. Current status of nonculture methods for diagnosis of invasive fungal infections. Clin. Microbiol. Rev. 15, 465-484 (2002 (Pubitemid 34761353)
84. Prella M, Bille J, Pugnale M et al. Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies. Diagn. Microbiol. Infect. Dis. 51, 95-101 (2005 (Pubitemid 40215418)
85. Walsh TJ, Merz WG, Lee JW et al. Diagnosis and therapeutic monitoring of invasive candidiasis by rapid enzymatic detection of serum d-arabinitol. Am. J. Med. 99, 164-172 (1995
86. Odabasi Z, Mattiuzzi G, Estey E et al. b-d-glucan as a diagnostic adjunct for invasive fungal infections: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin. Infect. Dis. 39, 199-205 (2004 (Pubitemid 38971490)
87. Ostrosky-Zeichner L, Alexander BD, Kett DH et al. Multicenter clinical evaluation of the (1-3) b-d-glucan assay as an aid to diagnosis of fungal infections in humans. Clin. Infect. Dis. 41, 654-659 (2005 (Pubitemid 41170353)
88. Sendid B, Poirot JL, Tabouret M et al. Combined detection of mannanaemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species. J. Med. Microbiol. 51, 433-442 (2002 (Pubitemid 34450601)
89. Khot PD, Fredricks DN. PCR-based diagnosis of human fungal infections. Expert Rev. Anti Infect. Ther. 7(10), 1201-1221 (2009
90. Landlinger C, Preuner S, Bašková L et al. Diagnosis of invasive fungal infections by a real-time panfungal PCR assay in immunocompromised pediatric patients. Leukemia 24, 2032-2038 (2010
91. Lamoth F, Jaton K, Prod'hom G et al. Multiplex blood PCR in combination with blood cultures for improvement of microbiological documentation of infection in febrile neutropenia. J. Clin. Microbiol. 48, 3510-3516 (2010
92. McMullan R, Metwally L, Coyle PV et al. A prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in non-neutropenic , critically ill adults. Clin. Infect. Dis. 46, 890-896 (2008 (Pubitemid 351417192)
93. Badiee P, Kordbacheh P, Alborzi A et al. Prospective screening in liver transplant recipients by panfungal PCR-ELISA for early diagnosis of invasive fungal infections. Liver Transpl. 13, 1011-1016 (2007 (Pubitemid 47163194)
94. Avni T, Leibovici L, Paul M. PCR diagnosis of invasive candidasis: Systematic review and meta-analysis. J. Clin. Microbiol. 49, 665-670 (2011
95. Lee BE, Cheung PY, Robinson JL et al. Comparative study of mortality and morbidity in premature infants (birth weight
96. Nguyen MH, Yu VL. Meningitis caused by Candida species: An emerging problem in neurosurgical patients. Clin. Infect. Dis. 21, 323-327 (1995
97. Celebi S, Hacimustafaoglu M, Caliskan S, Ildirim I. Cases with Candida meningitis. Presented at: National Pediatric Infectious Diseases Congress, Adana, Turkey, 26-29 October 2001.
98. Greene R. The role of radiology in the diagnosis of fungal infections. In:Diagnosis of Fungal Infections Maertens JA, Marr KA (Eds). Informa Healthcare, NY, USA, 41-63 (2007
99. Pappas PG, Bergamo B. Superficial and mucosal fungal infections. In:Diagnosis of Fungal Infections Maertens JA, Marr KA (Eds). Informa Healthcare, NY, USA, 153-169 (2007
100. Vazquez JA, Sobel JD. Candidiasis. In:Clinical Mycology Dismukes WE, Pappas PG, Sobel JD (Eds). Oxford University Press, NY, USA, 143-187 (2003
101. Sobel JD, Faro S, Force RW et al. Vulvovaginal candidiasis: Epidemiologic, diagnostic, and therapeutic considerations. Am. J. Obstet. Gynecol. 178, 203-211 (1998 (Pubitemid 28124116)
102. American Academy of Pediatrics. Candidiasis (moniliasis, thrush). In:Red Book: 2009 Report of the Committee on Infectious Diseases (28th Edition). Pickering LK, Baker CJ, Kimberlin DW, Long SS (Eds). American Academy of Pediatrics, IL, USA, 245-249 (2009
103. Pfaller MA, Diekema DJ, Ostrosky-Zeichner L et al. Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: Analysis and proposal for interpretive MIC breakpoints. J. Clin. Microbiol. 46, 2620-2629 (2008
104. Zaoutis TE, Jafri HS, Huang LM et al. A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients. Pediatrics 123, 877-884 (2009
105. Queiroz-Telles F, Berezin E, Leverger G et al. Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: Substudy of a randomized double-blind trial. Pediatr. Infect. Dis. J. 27, 820-826 (2008
106. Steinbach WJ, Perfect JR. Antifungal agents. In:Neonatal and Pediatric Pharmacology. Therapeutic Principles in Practice (3rd Edition) Yaffe SJ, Aranda JV (Eds). Lippincott Williams Wilkins, PA, USA, 459-475 (2005
107. Pfaller MA, Diekema DJ, Rinaldi MG. Antifungal drugs: Mechanisms of action, drug resistance, susceptibility testing, and assays of activity in biological fluids. In:Antibiotics in Laboratory Medicine (5th Edition). Lorian V (Ed.). Lippincott Williams & Wilkins, PA, USA, 226-265 (2005
108. Steinbach WJ. Antifungal agents in children. Pediatr. Clin. North Am. 52, 895-915 (2005 (Pubitemid 40733599)
109. Karlsson O, Lutsar I, Milligan PA. Population pharmacokinetic analysis of voriconazole plasma concentration data from pediatric studies. Antimicrob. Agents. Chemother. 53, 935-944 (2009
110. Gudlaugsson O. Attributable mortality of nosocomial candidemia, revisited. Clin. Infect. Dis. 34, 1172-1177 (2003 (Pubitemid 37372504)
111. Slavoski LA, Tunkel AR. Therapy of fungal meningitis. Clin. Neuropharmacol. 18, 195-112 (1995
112. Groll AH, Giri N, Petraitis V et al. Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system. J. Infect. Dis. 182, 274-282 (2000 (Pubitemid 30497814)
113. Lutsar I, Roffey S, Troke P. Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients. Clin. Infect. Dis. 37, 728-732 (2003 (Pubitemid 37100817)
114. Torres HA, Hachem RY, Chemaly RF, Kontoyiannis DP, Raad II. Posaconazole: A broad-spectrum triazole antifungal. Lancet Infect. Dis. 5, 775-785 (2005 (Pubitemid 41688982)
115. Sanchez-Portocarrero J, Martin-Rabadan P, Saldana CJ, Perez-Cecilia E. Candida cerebrospinal fluid shunt infection. Report of two new cases and review of the literature. Diagn. Microbiol. Infect. Dis. 20, 33-40 (1994). (Pubitemid 124010800)